SWIFTBIO CONSULTING LTD

Executive Summary

SWIFTBIO CONSULTING LTD is currently experiencing liquidity challenges and a significant decline in equity, indicative of financial stress despite asset growth. Immediate steps to strengthen working capital, manage costs, and formalise director funding are crucial to restore financial health and ensure sustainable operations.

View Full Analysis Report →
Company Documents

DateDescription
11/06/2511 June 2025 NewMicro company accounts made up to 2024-09-30

View Document

30/09/2430 September 2024 Annual accounts for year ending 30 Sep 2024

View Accounts

25/09/2425 September 2024 Confirmation statement made on 2024-09-14 with no updates

View Document

25/06/2425 June 2024 Micro company accounts made up to 2023-09-30

View Document

30/09/2330 September 2023 Annual accounts for year ending 30 Sep 2023

View Accounts

27/09/2327 September 2023 Confirmation statement made on 2023-09-14 with no updates

View Document

28/04/2328 April 2023 Micro company accounts made up to 2022-09-30

View Document

30/09/2230 September 2022 Annual accounts for year ending 30 Sep 2022

View Accounts

15/09/2215 September 2022 Confirmation statement made on 2022-09-14 with no updates

View Document


More Company Information